Global Plerixafor Market Growth (Status and Outlook) 2025-2031

December 2025 | 71 pages | ID: G285A1BF6F2EN
LP Information

Abstracts

According to this study, the global Plerixafor market size will reach US$ million by 2031.

Plerixafor (INN and USAN, trade name Mozobil) is an immunostimulant used to mobilize hematopoietic stem cells in cancer patients into the bloodstream.

United States market for Plerixafor is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Plerixafor is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Plerixafor is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Plerixafor players cover sanofi-aventis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Plerixafor Industry Forecast” looks at past sales and reviews total world Plerixafor sales in 2024, providing a comprehensive analysis by region and market sector of projected Plerixafor sales for 2025 through 2031. With Plerixafor sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Plerixafor industry.

This Insight Report provides a comprehensive analysis of the global Plerixafor landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Plerixafor portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Plerixafor market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Plerixafor and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Plerixafor.

This report presents a comprehensive overview, market shares, and growth opportunities of Plerixafor market by product type, application, key players and key regions and countries.

Segmentation by Type:

• 24MG/1.2ML

Segmentation by Application:

• Non-Hodgkin's lymphoma (NHL) Patients
• Multiple myeloma (MM) Patients

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• sanofi-aventis

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Plerixafor Market Size (2020-2031)
  2.1.2 Plerixafor Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Plerixafor by Country/Region (2020, 2024 & 2031)
2.2 Plerixafor Segment by Type
  2.2.1 24MG/1.2ML
2.3 Plerixafor Market Size by Type
  2.3.1 Plerixafor Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Plerixafor Market Size Market Share by Type (2020-2025)
2.4 Plerixafor Segment by Application
  2.4.1 Non-Hodgkin's lymphoma (NHL) Patients
  2.4.2 Multiple myeloma (MM) Patients
2.5 Plerixafor Market Size by Application
  2.5.1 Plerixafor Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Plerixafor Market Size Market Share by Application (2020-2025)

3 PLERIXAFOR MARKET SIZE BY PLAYER

3.1 Plerixafor Market Size Market Share by Player
  3.1.1 Global Plerixafor Revenue by Player (2020-2025)
  3.1.2 Global Plerixafor Revenue Market Share by Player (2020-2025)
3.2 Global Plerixafor Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PLERIXAFOR BY REGION

4.1 Plerixafor Market Size by Region (2020-2025)
4.2 Global Plerixafor Annual Revenue by Country/Region (2020-2025)
4.3 Americas Plerixafor Market Size Growth (2020-2025)
4.4 APAC Plerixafor Market Size Growth (2020-2025)
4.5 Europe Plerixafor Market Size Growth (2020-2025)
4.6 Middle East & Africa Plerixafor Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Plerixafor Market Size by Country (2020-2025)
5.2 Americas Plerixafor Market Size by Type (2020-2025)
5.3 Americas Plerixafor Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Plerixafor Market Size by Region (2020-2025)
6.2 APAC Plerixafor Market Size by Type (2020-2025)
6.3 APAC Plerixafor Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Plerixafor Market Size by Country (2020-2025)
7.2 Europe Plerixafor Market Size by Type (2020-2025)
7.3 Europe Plerixafor Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Plerixafor by Region (2020-2025)
8.2 Middle East & Africa Plerixafor Market Size by Type (2020-2025)
8.3 Middle East & Africa Plerixafor Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PLERIXAFOR MARKET FORECAST

10.1 Global Plerixafor Forecast by Region (2026-2031)
  10.1.1 Global Plerixafor Forecast by Region (2026-2031)
  10.1.2 Americas Plerixafor Forecast
  10.1.3 APAC Plerixafor Forecast
  10.1.4 Europe Plerixafor Forecast
  10.1.5 Middle East & Africa Plerixafor Forecast
10.2 Americas Plerixafor Forecast by Country (2026-2031)
  10.2.1 United States Market Plerixafor Forecast
  10.2.2 Canada Market Plerixafor Forecast
  10.2.3 Mexico Market Plerixafor Forecast
  10.2.4 Brazil Market Plerixafor Forecast
10.3 APAC Plerixafor Forecast by Region (2026-2031)
  10.3.1 China Plerixafor Market Forecast
  10.3.2 Japan Market Plerixafor Forecast
  10.3.3 Korea Market Plerixafor Forecast
  10.3.4 Southeast Asia Market Plerixafor Forecast
  10.3.5 India Market Plerixafor Forecast
  10.3.6 Australia Market Plerixafor Forecast
10.4 Europe Plerixafor Forecast by Country (2026-2031)
  10.4.1 Germany Market Plerixafor Forecast
  10.4.2 France Market Plerixafor Forecast
  10.4.3 UK Market Plerixafor Forecast
  10.4.4 Italy Market Plerixafor Forecast
  10.4.5 Russia Market Plerixafor Forecast
10.5 Middle East & Africa Plerixafor Forecast by Region (2026-2031)
  10.5.1 Egypt Market Plerixafor Forecast
  10.5.2 South Africa Market Plerixafor Forecast
  10.5.3 Israel Market Plerixafor Forecast
  10.5.4 Turkey Market Plerixafor Forecast
10.6 Global Plerixafor Forecast by Type (2026-2031)
10.7 Global Plerixafor Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Plerixafor Forecast

11 KEY PLAYERS ANALYSIS

11.1 sanofi-aventis
  11.1.1 sanofi-aventis Company Information
  11.1.2 sanofi-aventis Plerixafor Product Offered
  11.1.3 sanofi-aventis Plerixafor Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 sanofi-aventis Main Business Overview
  11.1.5 sanofi-aventis Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Plerixafor Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Plerixafor Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 24MG/1.2ML
Table 4. Plerixafor Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 5. Global Plerixafor Market Size by Type (2020-2025) & ($ millions)
Table 6. Global Plerixafor Market Size Market Share by Type (2020-2025)
Table 7. Plerixafor Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Plerixafor Market Size by Application (2020-2025) & ($ millions)
Table 9. Global Plerixafor Market Size Market Share by Application (2020-2025)
Table 10. Global Plerixafor Revenue by Player (2020-2025) & ($ millions)
Table 11. Global Plerixafor Revenue Market Share by Player (2020-2025)
Table 12. Plerixafor Key Players Head office and Products Offered
Table 13. Plerixafor Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Plerixafor Market Size by Region (2020-2025) & ($ millions)
Table 17. Global Plerixafor Market Size Market Share by Region (2020-2025)
Table 18. Global Plerixafor Revenue by Country/Region (2020-2025) & ($ millions)
Table 19. Global Plerixafor Revenue Market Share by Country/Region (2020-2025)
Table 20. Americas Plerixafor Market Size by Country (2020-2025) & ($ millions)
Table 21. Americas Plerixafor Market Size Market Share by Country (2020-2025)
Table 22. Americas Plerixafor Market Size by Type (2020-2025) & ($ millions)
Table 23. Americas Plerixafor Market Size Market Share by Type (2020-2025)
Table 24. Americas Plerixafor Market Size by Application (2020-2025) & ($ millions)
Table 25. Americas Plerixafor Market Size Market Share by Application (2020-2025)
Table 26. APAC Plerixafor Market Size by Region (2020-2025) & ($ millions)
Table 27. APAC Plerixafor Market Size Market Share by Region (2020-2025)
Table 28. APAC Plerixafor Market Size by Type (2020-2025) & ($ millions)
Table 29. APAC Plerixafor Market Size by Application (2020-2025) & ($ millions)
Table 30. Europe Plerixafor Market Size by Country (2020-2025) & ($ millions)
Table 31. Europe Plerixafor Market Size Market Share by Country (2020-2025)
Table 32. Europe Plerixafor Market Size by Type (2020-2025) & ($ millions)
Table 33. Europe Plerixafor Market Size by Application (2020-2025) & ($ millions)
Table 34. Middle East & Africa Plerixafor Market Size by Region (2020-2025) & ($ millions)
Table 35. Middle East & Africa Plerixafor Market Size by Type (2020-2025) & ($ millions)
Table 36. Middle East & Africa Plerixafor Market Size by Application (2020-2025) & ($ millions)
Table 37. Key Market Drivers & Growth Opportunities of Plerixafor
Table 38. Key Market Challenges & Risks of Plerixafor
Table 39. Key Industry Trends of Plerixafor
Table 40. Global Plerixafor Market Size Forecast by Region (2026-2031) & ($ millions)
Table 41. Global Plerixafor Market Size Market Share Forecast by Region (2026-2031)
Table 42. Global Plerixafor Market Size Forecast by Type (2026-2031) & ($ millions)
Table 43. Global Plerixafor Market Size Forecast by Application (2026-2031) & ($ millions)
Table 44. sanofi-aventis Details, Company Type, Plerixafor Area Served and Its Competitors
Table 45. sanofi-aventis Plerixafor Product Offered
Table 46. sanofi-aventis Plerixafor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 47. sanofi-aventis Main Business
Table 48. sanofi-aventis Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Plerixafor Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Plerixafor Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Plerixafor Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Plerixafor Sales Market Share by Country/Region (2024)
Figure 8. Plerixafor Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Plerixafor Market Size Market Share by Type in 2024
Figure 10. Plerixafor in Non-Hodgkin's lymphoma (NHL) Patients
Figure 11. Global Plerixafor Market: Non-Hodgkin's lymphoma (NHL) Patients (2020-2025) & ($ millions)
Figure 12. Plerixafor in Multiple myeloma (MM) Patients
Figure 13. Global Plerixafor Market: Multiple myeloma (MM) Patients (2020-2025) & ($ millions)
Figure 14. Global Plerixafor Market Size Market Share by Application in 2024
Figure 15. Global Plerixafor Revenue Market Share by Player in 2024
Figure 16. Global Plerixafor Market Size Market Share by Region (2020-2025)
Figure 17. Americas Plerixafor Market Size 2020-2025 ($ millions)
Figure 18. APAC Plerixafor Market Size 2020-2025 ($ millions)
Figure 19. Europe Plerixafor Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Plerixafor Market Size 2020-2025 ($ millions)
Figure 21. Americas Plerixafor Value Market Share by Country in 2024
Figure 22. United States Plerixafor Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Plerixafor Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Plerixafor Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Plerixafor Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Plerixafor Market Size Market Share by Region in 2024
Figure 27. APAC Plerixafor Market Size Market Share by Type (2020-2025)
Figure 28. APAC Plerixafor Market Size Market Share by Application (2020-2025)
Figure 29. China Plerixafor Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Plerixafor Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Plerixafor Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Plerixafor Market Size Growth 2020-2025 ($ millions)
Figure 33. India Plerixafor Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Plerixafor Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Plerixafor Market Size Market Share by Country in 2024
Figure 36. Europe Plerixafor Market Size Market Share by Type (2020-2025)
Figure 37. Europe Plerixafor Market Size Market Share by Application (2020-2025)
Figure 38. Germany Plerixafor Market Size Growth 2020-2025 ($ millions)
Figure 39. France Plerixafor Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Plerixafor Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Plerixafor Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Plerixafor Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Plerixafor Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Plerixafor Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Plerixafor Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Plerixafor Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Plerixafor Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Plerixafor Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Plerixafor Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Plerixafor Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Plerixafor Market Size 2026-2031 ($ millions)
Figure 52. APAC Plerixafor Market Size 2026-2031 ($ millions)
Figure 53. Europe Plerixafor Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Plerixafor Market Size 2026-2031 ($ millions)
Figure 55. United States Plerixafor Market Size 2026-2031 ($ millions)
Figure 56. Canada Plerixafor Market Size 2026-2031 ($ millions)
Figure 57. Mexico Plerixafor Market Size 2026-2031 ($ millions)
Figure 58. Brazil Plerixafor Market Size 2026-2031 ($ millions)
Figure 59. China Plerixafor Market Size 2026-2031 ($ millions)
Figure 60. Japan Plerixafor Market Size 2026-2031 ($ millions)
Figure 61. Korea Plerixafor Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Plerixafor Market Size 2026-2031 ($ millions)
Figure 63. India Plerixafor Market Size 2026-2031 ($ millions)
Figure 64. Australia Plerixafor Market Size 2026-2031 ($ millions)
Figure 65. Germany Plerixafor Market Size 2026-2031 ($ millions)
Figure 66. France Plerixafor Market Size 2026-2031 ($ millions)
Figure 67. UK Plerixafor Market Size 2026-2031 ($ millions)
Figure 68. Italy Plerixafor Market Size 2026-2031 ($ millions)
Figure 69. Russia Plerixafor Market Size 2026-2031 ($ millions)
Figure 70. Egypt Plerixafor Market Size 2026-2031 ($ millions)
Figure 71. South Africa Plerixafor Market Size 2026-2031 ($ millions)
Figure 72. Israel Plerixafor Market Size 2026-2031 ($ millions)
Figure 73. Turkey Plerixafor Market Size 2026-2031 ($ millions)
Figure 74. Global Plerixafor Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Plerixafor Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Plerixafor Market Size 2026-2031 ($ millions)